1. Home
  2. LAW vs ALLO Comparison

LAW vs ALLO Comparison

Compare LAW & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAW
  • ALLO
  • Stock Information
  • Founded
  • LAW 2013
  • ALLO 2017
  • Country
  • LAW United States
  • ALLO United States
  • Employees
  • LAW N/A
  • ALLO N/A
  • Industry
  • LAW Computer Software: Prepackaged Software
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LAW Technology
  • ALLO Health Care
  • Exchange
  • LAW Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • LAW 249.3M
  • ALLO 252.9M
  • IPO Year
  • LAW 2021
  • ALLO 2018
  • Fundamental
  • Price
  • LAW $6.26
  • ALLO $1.13
  • Analyst Decision
  • LAW Buy
  • ALLO Strong Buy
  • Analyst Count
  • LAW 2
  • ALLO 10
  • Target Price
  • LAW $6.75
  • ALLO $8.88
  • AVG Volume (30 Days)
  • LAW 116.1K
  • ALLO 3.0M
  • Earning Date
  • LAW 11-05-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • LAW N/A
  • ALLO N/A
  • EPS Growth
  • LAW N/A
  • ALLO N/A
  • EPS
  • LAW N/A
  • ALLO N/A
  • Revenue
  • LAW $148,024,000.00
  • ALLO N/A
  • Revenue This Year
  • LAW $7.13
  • ALLO N/A
  • Revenue Next Year
  • LAW $6.25
  • ALLO $100.00
  • P/E Ratio
  • LAW N/A
  • ALLO N/A
  • Revenue Growth
  • LAW 4.05
  • ALLO N/A
  • 52 Week Low
  • LAW $3.31
  • ALLO $0.86
  • 52 Week High
  • LAW $6.64
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • LAW 79.04
  • ALLO 47.86
  • Support Level
  • LAW $5.51
  • ALLO $1.09
  • Resistance Level
  • LAW $5.78
  • ALLO $1.21
  • Average True Range (ATR)
  • LAW 0.21
  • ALLO 0.07
  • MACD
  • LAW 0.04
  • ALLO 0.01
  • Stochastic Oscillator
  • LAW 82.09
  • ALLO 33.33

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: